<h3>Gainers</h3>
<ul>
<li>Virax Biolabs Group (NASDAQ:VRAX) stock increased by 76.7% to $0.18 during Monday's pre-market session. </li>
<li>Allogene Therapeutics (NASDAQ:ALLO) shares moved upwards by 34.21% to $3.65. The company's market cap stands at $663.0 million. </li>
<li>Spyre Therapeutics (NASDAQ:SYRE) stock rose 31.58% to $67.49. The company's market cap stands at $4.0 billion. </li>
<li>Revolution Medicines (NASDAQ:RVMD) shares rose 24.59% to $120.15. The company's market cap stands at $18.6 billion. </li>
<li>Cellectis (NASDAQ:CLLS) stock increased by 21.16% to $4.35. The market value of their outstanding shares is at $361.1 million. </li>
<li>ImageneBio (NASDAQ:IMA) shares moved upwards by 18.32% to $5.8. The company's market cap stands at $54.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Replimune Group (NASDAQ:REPL) stock fell 64.1% to $1.71 during Monday's pre-market session. The company's market cap stands at $373.3 million. </li>
<li>Beyond Air (NASDAQ:XAIR) shares declined by 12.43% to $0.69. The company's market cap stands at $8.2 million. </li>
<li>Cue Biopharma (NASDAQ:CUE) shares declined by 12.06% to $0.44. The market value of their outstanding shares is at $49.0 million. </li>
<li>iSpecimen (NASDAQ:ISPC) stock decreased by 11.87% to $0.11. The company's market cap stands at $3.7 million. </li>
<li>Zhengye Biotechnology (NASDAQ:ZYBT) shares fell 11.33% to $0.94. The company's market cap stands at $50.2 million. </li>
<li>BGM Group (NASDAQ:BGM) stock fell 9.51% to $0.31. The company's market cap stands at $68.6 million. 
See Also: www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ALLO

SYRE

VRAX

In Monday's pre-market session, Virax Biolabs Group (NASDAQ:VRAX) saw a significant gain of 76.7%, reaching $0.18. Other notable gainers included Allogene Therapeutics (NASDAQ:ALLO) up 34.21% to $3.65, and Spyre Therapeutics (NASDAQ:SYRE) rising 31.58% to $67.49. Conversely, Replimune Group (NASDAQ:REPL) experienced a sharp decline of 64.1%, dropping to $1.71. Beyond Air (NASDAQ:XAIR) and Cue Biopharma (NASDAQ:CUE) also saw losses of 12.43% and 12.06%, respectively.

12 Health Care Stocks Moving In Monday's Pre-Market Session